Annett Spudich

636 total citations
7 papers, 524 citations indexed

About

Annett Spudich is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Annett Spudich has authored 7 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Annett Spudich's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Annett Spudich is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Annett Spudich collaborates with scholars based in Switzerland and Germany. Annett Spudich's co-authors include Claudio L. Bassetti, Dirk M. Hermann, Ertuğrul Kılıç, Ülkan Kılıç, Heidi Wunderli‐Allenspach, Katharina Rentsch, Hongyi Xing, Hugo H. Marti, Bruno Oesch and Zeyun Guo and has published in prestigious journals such as Journal of Neuroscience, Nature Neuroscience and Brain.

In The Last Decade

Annett Spudich

7 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annett Spudich Switzerland	6	258	182	154	73	71	7	524
Maria Tikhonenko United States	7	287 1.1×	71 0.4×	34 0.2×	18 0.2×	43 0.6×	10	562
Arpna Srivastava India	12	261 1.0×	56 0.3×	56 0.4×	36 0.5×	9 0.1×	26	510
Muriel B. Sättler Germany	16	251 1.0×	184 1.0×	78 0.5×	23 0.3×	7 0.1×	22	784
Nathalie Lebeurrier France	8	212 0.8×	152 0.8×	45 0.3×	23 0.3×	10 0.1×	9	583
Ulrike Harms Germany	11	263 1.0×	80 0.4×	41 0.3×	20 0.3×	18 0.3×	12	527
Rayshad Gopaul Canada	8	272 1.1×	160 0.9×	119 0.8×	13 0.2×	12 0.2×	9	608
Moulinath Acharya India	14	387 1.5×	67 0.4×	41 0.3×	39 0.5×	13 0.2×	37	773
Andrew Sochacki United States	9	267 1.0×	51 0.3×	51 0.3×	8 0.1×	40 0.6×	16	537
Lucía Ayuso‐Peralta Spain	14	104 0.4×	40 0.2×	54 0.4×	14 0.2×	28 0.4×	33	470
Madalina Opreanu United States	8	275 1.1×	62 0.3×	30 0.2×	8 0.1×	47 0.7×	8	572

Countries citing papers authored by Annett Spudich

Since Specialization

Citations

This map shows the geographic impact of Annett Spudich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annett Spudich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annett Spudich more than expected).

Fields of papers citing papers by Annett Spudich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annett Spudich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annett Spudich. The network helps show where Annett Spudich may publish in the future.

Co-authorship network of co-authors of Annett Spudich

This figure shows the co-authorship network connecting the top 25 collaborators of Annett Spudich. A scholar is included among the top collaborators of Annett Spudich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annett Spudich. Annett Spudich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kılıç, Ertuğrul, Annett Spudich, Ülkan Kılıç, et al.. (2008). ABCC1: a gateway for pharmacological compounds to the ischaemic brain. Brain. 131(10). 2679–2689. 54 indexed citations

2.

Spudich, Annett, et al.. (2007). Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. Clinical Neurophysiology. 119(1). e5–e6. 5 indexed citations

3.

Kılıç, Ülkan, Ertuğrul Kılıç, Anne Järve, et al.. (2006). Human Vascular Endothelial Growth Factor Protects Axotomized Retinal Ganglion CellsIn Vivoby Activating ERK-1/2 and Akt Pathways. Journal of Neuroscience. 26(48). 12439–12446. 152 indexed citations

4.

Spudich, Annett, et al.. (2006). Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischaemia. Aktuelle Neurologie. 33(S 1). 3 indexed citations

5.

Hermann, Dirk M., Ertuğrul Kılıç, Annett Spudich, et al.. (2006). Role of drug efflux carriers in the healthy and diseased brain. Annals of Neurology. 60(5). 489–498. 50 indexed citations

6.

Spudich, Annett, Ertuğrul Kılıç, Hongyi Xing, et al.. (2006). Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nature Neuroscience. 9(4). 487–488. 139 indexed citations

7.

Spudich, Annett, Rico Frigg, Ertuğrul Kılıç, et al.. (2005). Aggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1. Neurobiology of Disease. 20(2). 442–449. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact